BACKGROUND: Gastro-oesophageal reflux disease (GERD) is a growing health-care problem with variable distribution. AIM: To assess GERD prevalence and risk factors and their possible correlation with pathophysiology in a population-based study. METHODS: Individuals aged 18-65 years were enrolled through random cluster sampling in Tehran. Previously validated self-administered questionnaires were used. RESULTS: Of the 2500 questionnaires, 2057 were analysed (mean age: 34.8 +/- 13.0 years, 55.1% female). Frequent GERD was seen in 18.2%. Minor symptoms increased prevalence. Female gender (OR: 1.55, 95% CI: 1.01-2.41), BMI >30 kg/m(2) (OR: 1.79, 95% CI: 1.03-3.12), less education (OR: 1.52, 95% CI: 1.02-2.27), smoking (OR: 1.83, 95% CI: 1.12-2.99), NSAID use (OR: 4.23, 95% CI: 1.66-10.74) and GERD in spouse (OR: 1.82, 95% CI: 1.18-2.82) were associated with frequent GERD on multivariable analysis. GERD in first-degree relatives (OR: 1.73, 95% CI: 1.23-2.43) and asthma (OR: 4.09, 95% CI: 1.27-13.15) correlated with infrequent GERD. Minor symptoms correlated with GERD history in first-degree relatives, coffee consumption and NSAID use. Prevalence in the past 3 months was similar to that in the past 12 months (P < 0.05). CONCLUSIONS: Gastro-oesophageal reflux disease is common in Tehran. The association of 'infrequent symptoms' with GERD history in first-degree relatives and 'frequent symptoms' with GERD history in spouse may point to the presence of yet unknown precipitating environmental factors inducing GERD in a genetically susceptible host. Minor GERD symptoms seem to have independent contribution to GERD. Assessing GERD in the past 3 months predicts prevalence in the past year.
BACKGROUND:Gastro-oesophageal reflux disease (GERD) is a growing health-care problem with variable distribution. AIM: To assess GERD prevalence and risk factors and their possible correlation with pathophysiology in a population-based study. METHODS: Individuals aged 18-65 years were enrolled through random cluster sampling in Tehran. Previously validated self-administered questionnaires were used. RESULTS: Of the 2500 questionnaires, 2057 were analysed (mean age: 34.8 +/- 13.0 years, 55.1% female). Frequent GERD was seen in 18.2%. Minor symptoms increased prevalence. Female gender (OR: 1.55, 95% CI: 1.01-2.41), BMI >30 kg/m(2) (OR: 1.79, 95% CI: 1.03-3.12), less education (OR: 1.52, 95% CI: 1.02-2.27), smoking (OR: 1.83, 95% CI: 1.12-2.99), NSAID use (OR: 4.23, 95% CI: 1.66-10.74) and GERD in spouse (OR: 1.82, 95% CI: 1.18-2.82) were associated with frequent GERD on multivariable analysis. GERD in first-degree relatives (OR: 1.73, 95% CI: 1.23-2.43) and asthma (OR: 4.09, 95% CI: 1.27-13.15) correlated with infrequent GERD. Minor symptoms correlated with GERD history in first-degree relatives, coffee consumption and NSAID use. Prevalence in the past 3 months was similar to that in the past 12 months (P < 0.05). CONCLUSIONS:Gastro-oesophageal reflux disease is common in Tehran. The association of 'infrequent symptoms' with GERD history in first-degree relatives and 'frequent symptoms' with GERD history in spouse may point to the presence of yet unknown precipitating environmental factors inducing GERD in a genetically susceptible host. Minor GERD symptoms seem to have independent contribution to GERD. Assessing GERD in the past 3 months predicts prevalence in the past year.
Authors: Majid A Almadi; Maitha A Almousa; Amani F Althwainy; Afnan M Altamimi; Hala O Alamoudi; Hiba S Alshamrani; Othman R Alharbi; Nahla A Azzam; Nazia Sadaf; Abdulrahman M Aljebreen Journal: Saudi J Gastroenterol Date: 2014 Jul-Aug Impact factor: 2.485
Authors: Arash Etemadi; Abdullah Gandomkar; Neal D Freedman; Mohsen Moghadami; Mohammad Reza Fattahi; Hossein Poustchi; Farhad Islami; Paolo Boffetta; Sanford M Dawsey; Christian C Abnet; Reza Malekzadeh Journal: Int J Epidemiol Date: 2017-12-01 Impact factor: 7.196
Authors: Mohammed A Alsaleem; Nabil J Awadalla; Shehata F Shehata; Awad Saeed Alsamghan; Mohammed A AlFlan; Marwan M Alhumaidi; Mohamed S Alwadai; Fahad S Althabet; Mohamad S Alzahrani; Safar A Alsaleem; Ahmed A Mahfouz Journal: Saudi Pharm J Date: 2021-04-24 Impact factor: 4.330